Loading...
menu
Search
Features
Markets
News
Resources
Pricing
Home
ETF
SLS
SLS
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
Latest SLS ETF News Today | Earnings, Events & Price Alerts
SLS News
Sellas Life Sciences Stock Soars Ahead of Key AML Trial Data
4h ago
stocktwits
SELLAS GPS Trial Progress Captivates Investors
4d ago
stocktwits
Sellas CEO Highlights Progress in Phase 3 REGAL Trial
Feb 23 2026
stocktwits
SELLAS Life Sciences Expands SLS009 Clinical Study with IMPACT-AML in Europe
Jan 14 2026
stocktwits
SELLAS Life Sciences Partners with IMPACT-AML to Advance SLS009 Clinical Trials
Jan 14 2026
Newsfilter
Oncolytics Biotech Fortifies IP Protection, Extends Pelareorep Commercial Runway to 2044
Jan 08 2026
Globenewswire
Intelligent Bio Solutions Plans $10 Million Private Placement, Shares Plunge 19.7%
Jan 02 2026
Benzinga
Ironwood Pharmaceuticals Issues FY26 Guidance, Shares Surge 57.7%
Jan 02 2026
Benzinga
ARS Pharma's Neffy Approved in China for Allergy Treatment
Jan 02 2026
NASDAQ.COM
Baidu Inc Proposes Spinoff of Kunlunxin H Shares, Stock Rises 12.3%
Jan 02 2026
Benzinga
FuelCell Energy Files for $200 Million Stock Offering, Shares Drop 8.9%
Dec 31 2025
Benzinga
Axsome Therapeutics Plans New Drug Application for AXS-12 in January, Shares Surge 16.1%
Dec 31 2025
Benzinga
OceanFirst Financial Corp. Announces $579 Million All-Stock Acquisition of Flushing, Shares Drop 7.4%
Dec 30 2025
Benzinga
CapsoVision Inc. Submits FDA 510(k) Application, Shares Surge 8.4%
Dec 30 2025
Benzinga
SELLAS Life Sciences Extends Survival in AML Patients in REGAL Trial
Dec 30 2025
NASDAQ.COM
SELLAS Life Sciences Shares Surge 16.72% on New Trial Updates
Dec 29 2025
Benzinga
Show More News
